“…The [ 2 H 5 ]phenylalanine infusion started 1.5 h before the other isotopes, then all continued for 6 h, with clamp from 4.5 to 7.5 h with: human insulin (primed, then 0.98‐1.3 mU [kg FFM −1 ] min −1 , Humulin R; Eli Lilly Canada Inc, Toronto, ON, Canada); octreotide (35.3 ng [kg FFM −1 ] min −1 , Omega, Montreal, QC, Canada); glucagon (0.94 ng [kg FFM −1 ] min −1 , Eli Lilly); and human growth hormone (hGH; 3.53 ng [kg FFM −1 ] min −1 , Saizen, EMD Serono, Canada). Concurrently, 20% low‐enriched 1 3 C‐glucose (Avebe b.a., Foxhol, Netherlands) and 10% AA solution (TrophAmine, B. Braun Medical, Irvine, CA) were infused at variable rates to clamp glucose at 8 mmol l −1 and branched‐chain amino acids (BCAA), at postprandial concentrations , both based on 5‐min interval measurements. Blood was collected hourly for substrates, hormones, and isotopic enrichment and at 10‐min intervals from 2.5‐3 h to 5.5–6 h. L‐[1‐ 13 C] leucine kinetics were calculated using plasma 1‐[ 13 C] α‐ketoisocaproic acid (KIC) enrichment (reciprocal model) .…”